Literature DB >> 1277137

Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

K R Weishaupt, C J Gomer, T J Dougherty.   

Abstract

Singlet oxygen, a metastable state of normal triplet oxygen, has been identified as the cytotoxic agent that is probably responsible for in vitro inactivation of TA-3 mouse mammary carcinoma cells following incorporation of hematoporphyrin and exposure to red light. This photodynamic inactivation can be completely inhibited by intracellular 1,3-diphenylisobenzofuran. This very efficient singlet oxygen trap is not toxic to the cells nor does it absorb the light responsible for hematoporphyrin activation. We have found that the singlet oxygen-trapping product, o-dibenzoylbenzene, is formed nearly quantitatively intracellularly when both the furan and hematoporphyrin are present during illumination but not when only the furan is present during illumination. The protective effect against photodynamic inactivation of the TA-3 cells afforded by 1,3-diphenylisobenzofuran coupled with the nearly quantitative formation of the singlet oxygen-trapping product indicates that singlet oxygen is the probable agent responsible for toxicity in this system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1277137

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  175 in total

1.  An indwelling brachytherapy balloon catheter: potential use as an intracranial light applicator for photodynamic therapy.

Authors:  H Hirschberg; S Madsen; K Lote; T Pham; B Tromberg
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Lutetium Texaphyrin: A New Therapeutic Tool for Human Atherosclerosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-10

3.  Enhancement of photodynamic therapy in gastric cancer cells by removal of iron.

Authors:  W C Tan; N Krasner; P O'Toole; M Lombard
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

4.  Selective cell targeting with light-absorbing microparticles and nanoparticles.

Authors:  Costas M Pitsillides; Edwin K Joe; Xunbin Wei; R Rox Anderson; Charles P Lin
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

5.  Analysis of mitochondria, endoplasmic reticulum and actin filaments after PDT with AlPcS(4).

Authors:  S D R M Ferreira; A C Tedesco; G Sousa; R A Zângaro; N S Silva; M T T Pacheco; C Pacheco-Soares
Journal:  Lasers Med Sci       Date:  2004-01-14       Impact factor: 3.161

6.  Evaluation of diethyl-3-3'-(9,10-anthracenediyl)bis acrylate as a probe for singlet oxygen formation during photodynamic therapy.

Authors:  David Kessel; Michael Price
Journal:  Photochem Photobiol       Date:  2012-03-01       Impact factor: 3.421

7.  Response of human endometrium and ovarian carcinoma cell-lines to photodynamic therapy.

Authors:  G H Raab; A F Schneider; W Eiermann; H Gottschalk-Deponte; R Baumgartner; W Beyer
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

8.  Insights into photodynamic therapy dosimetry: simultaneous singlet oxygen luminescence and photosensitizer photobleaching measurements.

Authors:  Mark T Jarvi; Michael S Patterson; Brian C Wilson
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

Review 9.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

10.  Interactions with glutathione S-transferases of porphyrins used in photodynamic therapy and naturally occurring porphyrins.

Authors:  A Smith; I Nuiry; Y C Awasthi
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.